Smoking may be considered an established risk factor for sporadic ALS

被引:115
|
作者
Armon, Carmel [1 ]
机构
[1] Tufts Univ, Sch Med, Baystate Med Ctr, Springfield, MA 01199 USA
关键词
AMYOTROPHIC-LATERAL-SCLEROSIS; LONGITUDINAL GOMPERTZIAN ANALYSIS; RANDOMIZED CONTROLLED-TRIAL; ESTROGEN PLUS PROGESTIN; CIGARETTE-SMOKING; POSTMENOPAUSAL WOMEN; MORTALITY; ASSOCIATION; POPULATION; SUSCEPTIBILITY;
D O I
10.1212/WNL.0b013e3181c1df48
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: A 2003 evidence-based review of exogenous risk factors for sporadic amyotrophic lateral sclerosis (ALS) identified smoking as the only risk factor that attained "probable" (more likely than not) status, based on 2 class II studies. The purpose of the current, evidence-based, update was to see if the conclusion of the previous review needed to be modified, based on studies published since. Methods: A Medline literature search was conducted for the period between 2003 and April 2009 using the search terms smoking and (ALS or "amyotrophic lateral sclerosis" or MND or "motor neuron disease"). The references of primary articles and reviews were checked to assure completeness of the search. Primary articles published since the previous review were classified as before. Results: Twenty-eight titles were identified, but only 7 articles met inclusion criteria. Of these, 1 provided class II evidence, and 1 class III evidence: both showed increased risk of ALS with smoking. The class II study showed a dose-response effect, and risk decreasing with number of years since quitting smoking. Five articles provided class IV or V evidence, which may not be relied upon to draw conclusions. Conclusions: Smoking may be considered an established risk factor for sporadic amyotrophic lateral sclerosis (ALS) (level A rating; 3 class II studies, 1 class III study). Evidence-based analysis of epidemiologic data shows concordance among results of better-designed studies linking smoking to ALS, and lets those results drive the conclusions. Neurology (R) 2009; 73: 1693-1698
引用
收藏
页码:1693 / 1698
页数:6
相关论文
共 50 条
  • [1] SMOKING MAY BE CONSIDERED AN ESTABLISHED RISK FACTOR FOR SPORADIC ALS
    Fang, Fang
    Ye, Weimin
    NEUROLOGY, 2010, 74 (23) : 1927 - 1927
  • [2] SMOKING MAY BE CONSIDERED AN ESTABLISHED RISK FACTOR FOR SPORADIC ALS Reply
    Armon, Carmel
    NEUROLOGY, 2010, 74 (23) : 1928 - 1929
  • [3] Genetic risk factors for sporadic ALS
    Jones N.
    Nature Reviews Neurology, 2009, 5 (11) : 579 - 579
  • [4] Smoking Is Not a Risk Factor for Sporadic Amyotrophic Lateral Sclerosis in an Australian Population
    Pamphlett, Roger
    Ward, Elizabeth Cochran
    NEUROEPIDEMIOLOGY, 2012, 38 (02) : 106 - 113
  • [5] The evolving genetic risk for sporadic ALS
    Gibson, Summer B.
    Downie, Jonathan M.
    Tsetsou, Spyridoula
    Feusier, Julie E.
    Figueroa, Karla P.
    Bromberg, Mark B.
    Jorde, Lynn B.
    Pulst, Stefan M.
    NEUROLOGY, 2017, 89 (03) : 226 - 233
  • [6] Apolipoprotein E ε2 may be a risk factor for sporadic frontotemporal dementia
    Lehmann, DJ
    Smith, AD
    Combrinck, M
    Barnetson, L
    Joachim, C
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 69 (03): : 404 - 405
  • [7] SMN1 gene, but not SMN2, is a risk factor for sporadic ALS
    Corcia, P.
    Camu, W.
    Halimi, J. -M.
    Vourc'h, P.
    Antar, C.
    Vedrine, S.
    Giraudeau, B.
    de Toffol, B.
    Andres, C. R.
    NEUROLOGY, 2006, 67 (07) : 1147 - 1150
  • [8] Smoking May Represent an Independent Risk Factor for the Development of Acute Pancreatitis
    Munigala, Satish
    Gelrud, Andres
    Agarwal, Banke
    Conwell, Darwin
    Scherrer, Jeffrey
    GASTROENTEROLOGY, 2013, 144 (05) : S273 - S273
  • [9] Exogenous risk factors in sporadic ALS: a review of the literature
    Gil, J.
    Funalot, B.
    Torny, F.
    Lacoste, M.
    Couratier, P.
    REVUE NEUROLOGIQUE, 2007, 163 (11) : 1021 - 1030
  • [10] Can vitamin D deficiency be considered a risk factor be considered a risk factor in luminal breast cancer?
    Fernandez Madrigal, Laura
    Rodriguez Garces, Maria Yeray
    Castano Lopez, Miguel Angel
    Bayo Calero, Juan Lucas
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)